Esteban Ruben Rivera-Rivera

Dr. Esteban Ruben Rivera-Rivera

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2026 in Neurology
Verified
Journal Article
Closed access
NNNoah Lee Ahmad Nawabi
Noah Lee Ahmad Nawabi
EREsteban Ruben Rivera-Rivera
Esteban Ruben Rivera-Rivera
DWDaniel de Wilde
Daniel de Wilde
JKJohn L. Kilgallon
John L. Kilgallon
DNDavid I. Nawabi
David I. Nawabi
JBJoshua Bernstock
Joshua Bernstock
Ischemic stroke remains a leading cause of death and disability worldwide, with large vessel occlusion (LVO) accounting for a disproportionate share of poststroke morbidity. Early identification of LVO is essential for timely intervention with endovascular thrombectomy; however, the clinical scales currently used for triage vary widely in their application and accuracy. This study assesses the diagnostic performance of clinical stroke scales in predicting LVO. A systematic review was conducted to identify studies evaluating the diagnostic accuracy of prehospital stroke scales for detecting LVO. Pooled sensitivity and specificity were estimated using a bivariate random-effects model, with diagnostic performance further assessed through summary receiver operating characteristic (ROC) curves and area under the curve (AUC) analysis. A Bayesian network meta-analysis was conducted to rank the scales using surface under the cumulative ranking (SUCRA) probabilities, and post hoc analyses were performed to evaluate publication bias. A total of 58 studies comprising 58,381 patients and 33 unique stroke scales were included in the final analysis. The studies, published between 2014 and 2023, were primarily conducted in North America (50%) and Europe (26%), with a median sample size of 473 participants. Pooled sensitivity ranged from 0.30 (HEMIPARESIS) to 0.99 (LARIO) while specificity varied from 0.34 (FANG) to 0.94 (HEMIPLEGIA). Among the highest-performing scales overall were LARIO (AUC = 0.983), FPSS (AUC = 0.896), FACE2AD (AUC = 0.876), and ACT-FAST (AUC = 0.873). In prehospital settings, FPSS (AUC = 0.896), FAST VAN (AUC = 0.878), and FACE2AD (AUC = 0.876) demonstrated strong performance while LARIO (AUC = 0.983) and ACT-FAST (AUC = 0.883) showed the highest accuracy in hospital settings. Bayesian network meta-analysis identified POMONA (SUCRA = 0.877), NIHSS (0.856), sNIHSS EMS (0.854), G-FAST (0.823), and SAFE (0.788) as the top-ranked scales. Funnel plot analysis revealed minimal publication bias among the most frequently evaluated tools, including RACE, CPSS, and NIHSS. Numerous clinical scales are available for detecting LVO in the prehospital setting. While several demonstrate strong performance in specific contexts, there remains a clear need for a simple, accurate, and generalizable tool to reliably identify patients with LVO across diverse clinical environments.

6 October 2025 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
EREsteban Ruben Rivera-Rivera
Esteban Ruben Rivera-Rivera
AAAlexander I. Acevedo-Jetter
Alexander I. Acevedo-Jetter
ACAlejandro E. Cedeño-Morán
Alejandro E. Cedeño-Morán
GTGrecia Negron Torres
Grecia Negron Torres
RARodolfo Elias Alcedo-Guardia
Rodolfo Elias Alcedo-Guardia
BACKGROUND: Stroke is the leading cause of disability and the fifth leading cause of death nationwide, with large-vessel occlusions (LVOs) contributing significantly to this burden. The risk of LVO increases in hypercoagulable states such as pregnancy; however, LVOs in pregnancy are rare. Management of this condition lacks well-established guidelines due to the exclusion of pregnant women from clinical trials. Case reports of alteplase and mechanical thrombectomy (MT) use during pregnancy suggest therapeutic potential; however, there is less evidence for agents such as tenecteplase (TNK). OBSERVATIONS: The authors present the case of a 27-year-old woman, G5P2A2, at 4 weeks’ gestation who presented with seizure-like activity, expressive aphasia, and right-sided hemiparesis, NIH Stroke Scale score of 21. The patient was diagnosed with an ischemic stroke. TNK was administered without symptom resolution, and the patient was transferred to the authors’ center. Imaging demonstrated left M2 occlusion, and MT was performed successfully. The patient carried the pregnancy to term and delivered a healthy infant at 37 weeks. LESSONS: To the authors’ knowledge, this represents the first formally reported case of LVO treated with TNK and MT in the first trimester of pregnancy. More data are needed to determine whether these interventions are safe for patients with LVOs during the first trimester of pregnancy. https://thejns.org/doi/10.3171/CASE25126

15 September 2025 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
CCCarlos E. Calderón-Valero
Carlos E. Calderón-Valero
EREsteban Ruben Rivera-Rivera
Esteban Ruben Rivera-Rivera
EPEmil Pastrana-Ramírez
Emil Pastrana-Ramírez
JVJuan C. Vicenty-Padilla
Juan C. Vicenty-Padilla
BACKGROUND: Traumatic vertebral artery injury (TVAI) is a serious yet underdiagnosed complication of cervical spine trauma, with an incidence ranging from 0.1% to 3.2%. While its neurological sequelae vary, the risk of vertebrobasilar ischemia can be as high as 33.3%. The authors present a rare case of bilateral vertebral artery occlusion with concomitant basilar artery occlusion following C4–5 anterolisthesis. OBSERVATIONS: The patient initially exhibited no clinical signs of vertebrobasilar ischemia. Diagnosis was achieved through vascular imaging, and successful endovascular thrombectomy with thrombus removal was performed. Unique to this case, manual cervical reduction was carried out in the endovascular suite while maintaining catheter placement in an effort to prevent recurrent dissection or emboli migration. LESSONS: Given the transient nature of vertebrobasilar ischemia, repeated imaging and neurological monitoring are crucial for timely intervention. This case highlights the importance of establishing standardized screening and treatment protocols to optimize outcomes and prevent further complications in patients with TVAI. https://thejns.org/doi/10.3171/CASE25155

18 May 2026 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
EREsteban Ruben Rivera-Rivera
Esteban Ruben Rivera-Rivera
KCKaren S. Chen
Karen S. Chen
JBJoshua Bernstock
Joshua Bernstock
NPNirav J. Patel
Nirav J. Patel
GMGisela Murray-Ortiz
Gisela Murray-Ortiz
JVJuan Vicenty-Padilla
Juan Vicenty-Padilla
BACKGROUND: Vein of Galen malformations (VOGMs) are congenital arteriovenous shunts that typically present in neonates and infants. Symptomatic neonates have a poor prognosis and face high mortality without dedicated neonatal intensive care and pediatric neurointervention in specialized centers. OBSERVATIONS: The authors present the case of a 47-year-old Puerto Rican female with a history of chronically compensated heart failure, progressive cognitive decline, and new-onset seizures. On presentation, the patient had a Glasgow Coma Scale score of 6, and CT imaging revealed intraventricular hemorrhage, extensive parenchymal calcifications, and hydrocephalus. An external ventricular drain was urgently placed, and further workup at the authors’ institution, including CT angiography and digital subtraction angiography, led to the diagnosis of a choroidal VOGM. The patient’s family opted for withdrawal of care without pursuing further neurosurgical intervention. LESSONS: The presentation of a choroidal VOGM at this advanced age is exceptionally rare. This case highlights the importance of understanding the presentations and consequences of this life-threatening condition, as well as considering endovascular or microsurgical intervention. Specifically, workup for cerebrovascular abnormalities should be strongly considered in patients with neurodegenerative presentations at atypical ages without a clear cause, as early diagnosis and management can significantly impact patient outcomes. https://thejns.org/doi/10.3171/CASE25684

30 March 2026
Verified
Journal Article
Open access
EREsteban Ruben Rivera-Rivera
Esteban Ruben Rivera-Rivera
AVAdriana S. Vázquez-Medina
Adriana S. Vázquez-Medina
CSCamille L. Santiago-Negron
Camille L. Santiago-Negron
HMHiram Maldonado
Hiram Maldonado
SESamuel Estronza
Samuel Estronza
EPEmil A. Pastrana
Emil A. Pastrana
Spinal ependymomas are the most common intramedullary spinal cord tumors in adults but rarely span multiple vertebral segments. Giant intradural intramedullary spinal ependymomas are exceedingly rare and pose diagnostic and surgical challenges due to their size and location. The authors report the case of a 31-year-old female who presented with progressive neck pain, lower extremity weakness, and sensory deficits. MRI revealed a large intramedullary lesion extending 11 spinal levels from C1 to T4. Gross-total en bloc resection of a 16-cm intramedullary ependymoma was achieved via C1–T4 laminectomy with posterior midline myelotomy, guided by multimodal intraoperative neuromonitoring. Pathological examination revealed a WHO grade 2 ependymoma. Postoperative MRI confirmed no residual tumor. The patient experienced transient postoperative motor deficits with gradual neurological recovery noted at follow-up. This case represents one of the largest reported intramedullary spinal ependymomas in the literature and demonstrates the feasibility of gross-total resection using a posterior longitudinal midline myelotomy approach. Successful management was facilitated by careful microsurgical technique and intraoperative neuromonitoring. Early recognition and timely surgical intervention are critical in optimizing outcomes in patients with spinal ependymomas; however, patients with multilevel intramedullary tumors will likely have residual neurological deficits. https://thejns.org/doi/10.3171/CASE25686

16 December 2025 in Epidemiologia
Verified
Journal Article
Open access
PDF file
EPEric J Pérez-Pérez
Eric J Pérez-Pérez
EREsteban Ruben Rivera-Rivera
Esteban Ruben Rivera-Rivera
NFNatasha Frontera
Natasha Frontera
ACAlejandro Cedeño-Moran
Alejandro Cedeño-Moran
CCCamelia Carvajal-Matta
Camelia Carvajal-Matta
MVMiguel Mayol Del Valle
Miguel Mayol Del Valle
Objectives: Neural tube defects such as myelomeningocele (MMC) remain a significant public health concern despite prevention efforts. Public health measures have reduced the global MMC incidence, but socioeconomic disparities may limit their impact. Puerto Rico (PR) is a United States (US) territory; however, its socioeconomic landscape is vastly different, which may contribute to differences in MMC incidence. In this study, we aimed to compare the differences in MMC incidence and annual variability between PR and the US. Materials and Methods: Data on MMC incidence for the US was obtained from the Centers for Disease Control’s National Vital Statistics Reports, and data for PR from the Puerto Rico Birth Defects Surveillance and Prevention System. Annual percentage change (APC) was used to evaluate year-to-year variation, and multiple linear regression analysis was applied to compare incidence rates. Results: The mean annual MMC incidence in 1996–2020 was 4.88 per 10,000 live births in PR (SD = 1.86), and 1.78 (SD = 0.35) in the US, with an estimated mean difference of 3.11 (p < 0.001). APCs during this period varied significantly, ranging from +200% to −63%. A subgroup analysis after folic acid fortification efforts in PR (1999–2020) showed a persistently elevated incidence in PR (mean = 4.41, SD = 1.33) vs. US (mean = 1.67, SD = 0.25), with an estimated mean difference of 2.72 (p < 0.001). Conclusions: Despite folic acid fortification and public health interventions, MMC incidence in PR remains higher and more variable. These findings underscore the need for improved disease reporting and targeted, region-specific preventive strategies.